BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3473070)

  • 1. Effects on the breast of drugs used in fertility regulation.
    Mauvais-Jarvis P
    Hum Reprod; 1987 Feb; 2(2):159-62. PubMed ID: 3473070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
    King RJ
    Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and breast disease.
    McGonigle KF; Huggins GR
    Fertil Steril; 1991 Nov; 56(5):799-819. PubMed ID: 1936311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
    Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
    Pike MC; Spicer DV; Dahmoush L; Press MF
    Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J; Schaaps JP; Lambotte R
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol has progestin-like actions on the human endometrium.
    Kokko E; Jänne O; Kauppila A; Rönnberg L; Vihko R
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):588-93. PubMed ID: 6461996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol/progesterone interaction in normal and pathologic breast cells.
    Mauvais-Jarvis P; Kuttenn F; Gompel A
    Ann N Y Acad Sci; 1986; 464():152-67. PubMed ID: 3524347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins and breast cancer: an epidemiologic review.
    Staffa JA; Newschaffer CJ; Jones JK; Miller V
    Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
    Kistner RW
    Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.